doi: 10.1093/neuonc/noab106
Pooled safety data across 12 placebo-controlled clinical studies of glycemic control in adults with T2D 1 Adverse reactions reported in 2% of adults taking FARXIGA 10 mg (n=1193) vs placebo (n=1393) included female genital mycotic infections (6.9% vs 1.5%), nasopharyngitis (6.3% vs 6.2%), UTIs (4.3% vs 3.7%), back pain (4.2% vs 3.2%), increased urination (3.8% vs 1.7%), male genital mycotic infections (2.7% vs 0.3%), nausea (2.5% vs 2.4%), dyslipidemia (2.5% vs 1.5%), influenza (2.3% vs 2.3%), and discomfort with urination (2.1% vs 0.7%)
That work was on full display during the 2026 PFACQ Annual Panel, The Future of Supportive Care: Its More Than Pain Management
Taken together with evidence that EAT expresses GLP-1R and that GLP-1RAs can reduce EAT volume, this finding further indicates that GLP-1RAs may have the potential to mitigate AF risk (26)
Recommended areas include the abdomen (staying at least 2 inches away from your belly button), the front and middle sections of your thigh, or the upper arm
Excellent Performance: With reverse polarity and current limit protection, laser proof temperature compensation,programmable adjustment